✦ LIBER ✦

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial

✍ Scribed by Emaus, N. (author);Gjesdal, C. G. (author);Almås, B. (author);Christensen, M. (author);Grimsgaard, A. S. (author);Berntsen, G. K.R. (author);Salomonsen, L. (author);Fønnebø, V. (author)

Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 187 KB
Volume: 21
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-009-1126-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vitamin K2 supplementation does not infl

Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial

✍ Emaus, N. (author);Gjesdal, C. G. (author);Almås, B. (author);Christensen, M. (a 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 187 KB

Calcitriol does not prevent bone loss in

Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial

✍ C. F. McDonald; R. M. D. Zebaze; E. Seeman 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 148 KB

The vitamin D analogue 2MD increases bon

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial

✍ Hector F DeLuca; Wendy Bedale; Neil Binkley; J Chris Gallagher; Michael Bolognes 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 215 KB 👁 1 views

## Abstract Most osteoporosis drugs act by inhibiting bone resorption. A need exists for osteoporosis therapies that stimulate new bone formation. 2‐Methylene‐19‐nor‐(20__S__)‐1α,25‐dihydroxyvitamin D~3~ (2MD) is a vitamin D analogue that potently stimulates bone formation activity in vitro and in